CHPA President
This article was originally published in The Rose Sheet
Executive Summary
FDA Senior Associate Commissioner for Communications and Constituent Relations Linda Suydam to head CHPA as president after leaving her post June 1. Suydam, who has worked for FDA for 21 years, has managed agency activities including orphan products, special health and women's health, FDA says. CHPA board member Robert Donovan has served as interim president since Jan. 15 following the departure of President Michael Maves, MD (1"The Rose Sheet" Dec. 24, 2001, In Brief)...
You may also be interested in...
CHPA interim prez
Consultant and longtime board member Robert Donovan will assume leadership post Jan. 15 upon departure of President Michael Maves, MD. Donovan and his wife will take up residence in D.C. area while maintaining their Connecticut home. An OTC industry veteran with ties to supplement industry, Donovan accepted CHPA Chairman Michael Valentino's job offer Dec. 16, is slated to visit association's offices the week of Dec. 24 and begin work Jan 2. Currently president of the Council on Family Health, Donovan said he will remain involved with the nonprofit educational organization through his leadership role at CHPA but would turn over decision-making duties to CFH Chairman Arthur Hayes, MD. Search for Maves' permanent replacement expected to take about six months...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.